Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions ; volume:10 ; number:1 ; day:15 ; month:9 ; year:2010 ; pages:1-11 ; date:12.2010
BMC pulmonary medicine ; 10, Heft 1 (15.9.2010), 1-11, 12.2010
- Creator
-
Neyt, Mattias
- Contributor
-
Devriese, Stephan
Thiry, Nancy
Van den Bruel, Ann
SpringerLink (Online service)
- DOI
-
10.1186/1471-2466-10-47
- URN
-
urn:nbn:de:1111-2016071615744
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Neyt, Mattias
- Devriese, Stephan
- Thiry, Nancy
- Van den Bruel, Ann
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness and cost-utility of a digital technology-driven hierarchical healthcare screening pattern in China
Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
Cost–utility and cost–benefit analyses of school-based obesity prevention program
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Functional outcome and cost-effectiveness of pulsed electromagnetic fields in the treatment of acute scaphoid fractures: a cost-utility analysis
Prevention of low back pain: effect, cost-effectiveness, and cost-utility of maintenance care – study protocol for a randomized clinical trial
Cost–utility analysis of a palliative care program in Colombia
The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: A UK-based cost-utility analysis
The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis
Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms
Economic efficiency and QALY-based cost-utility analysis in health care
Cost-effectiveness and cost-utility of a digital technology-driven hierarchical healthcare screening pattern in China
Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
Cost–utility and cost–benefit analyses of school-based obesity prevention program
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Functional outcome and cost-effectiveness of pulsed electromagnetic fields in the treatment of acute scaphoid fractures: a cost-utility analysis
Prevention of low back pain: effect, cost-effectiveness, and cost-utility of maintenance care – study protocol for a randomized clinical trial
Cost–utility analysis of a palliative care program in Colombia
The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: A UK-based cost-utility analysis
The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis
Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms
Economic efficiency and QALY-based cost-utility analysis in health care
Cost-effectiveness and cost-utility of a digital technology-driven hierarchical healthcare screening pattern in China
Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
Cost–utility and cost–benefit analyses of school-based obesity prevention program
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Functional outcome and cost-effectiveness of pulsed electromagnetic fields in the treatment of acute scaphoid fractures: a cost-utility analysis
Prevention of low back pain: effect, cost-effectiveness, and cost-utility of maintenance care – study protocol for a randomized clinical trial
Cost–utility analysis of a palliative care program in Colombia
The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: A UK-based cost-utility analysis
The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis
Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms